Synteny Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About Synteny Lifesciences
Synteny Lifesciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 November 2013 and has a history of 11 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Katla and Sravanthi Katla serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2013PTC090907
-
Company No.
090907
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Nov 2013
-
Date of AGM
25 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Synteny Lifesciences Private Limited offer?
Synteny Lifesciences Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research, Pharmaceutical Services, Biotechnology Services, Data Entry & Data Processing Service, Data Management.
Who are the key members and board of directors at Synteny Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Katla
|
Director | 07-Nov-2013 | Current |
|
Sravanthi Katla
|
Director | 20-Feb-2015 | Current |
Financial Performance of Synteny Lifesciences.
Synteny Lifesciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synteny Lifesciences?
In 2017, Synteny Lifesciences had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mtw Labs Innovations India Private LimitedAshok Katla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synteny Lifesciences?
Unlock and access historical data on people associated with Synteny Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synteny Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synteny Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
